Shionogi Presents Real-World and Surveillance Data Reinforcing Role of Cefiderocol Across Range of Patient Populations and Difficult-to-Treat Infections｜ SHIONOGI

Antimicrobial Resistance

AMR is a major health burden that urgently needs to be addressed.¹¹ Globally, in 2021, there were 1.14 million deaths attributable to bacterial AMR.¹³ Infections caused by carbapenem-resistant Gram-negative bacteria are…